A study led by André Veillette, a researcher at the Montreal Clinical Research Institute (IRCM) and a professor in the ...

Iams, MD, MSCI, discussed potential ways to determine which patients benefit most from additional therapy for extensive-stage ...

Lutetium Lu 177 vipivotide tetraxetan combined with ARPI and ADT improved rPFS in PSMA-positive mHSPC patients compared to ARPI and ADT alone. Lutetium Lu 177 vipivotide tetraxetan significantly ...

Those silver strands could be an outward sign of the body’s own intricate defences against cancer, a recent study in mice has ...

In this video, Leo I. Gordon, MD, FACP, discusses highlights from a debate at Lymphoma, Leukemia & Myeloma Congress on the evolving treatment landscape for relapsed or refractory diffuse large B-cell ...

Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a ...

This Research Topic seeks to advance the understanding of the complex, bidirectional relationship between cardiometabolic risk factors and cancer. The ...

CAR T and CAR Treg therapies revolutionize cancer treatment through automation, scalability, and global manufacturing innovation.

Q3 2025 Earnings Call Transcript November 4, 2025 SOPHiA GENETICS S.A. misses on earnings expectations. Reported EPS is $-0.3 ...

Cannabidiol (CBD) inhibits tumor growth in triple-negative breast cancer (TNBC), a highly aggressive form that lacks targeted ...

Drug resistance remains the foremost challenge to durable cancer control. Tumors evolve dynamic mechanisms to evade therapy through target mutations, ...

Diana Jupp, CEO of Pancreatic Cancer UK, said: “The breath test has the potential to revolutionise the early detection of pancreatic cancer. It is, undoubtedly, the most significant step toward a ...